What You Should Know About Johnson & Johnson's Newest COVID Vaccine Warning
Three months ago, the Food and Drug Administration put a warning on the label of Johnson & Johnson's (NYSE: JNJ) COVID-19 vaccine related to possible rare blood clotting problems. In this Motley Fool Live video, captured on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss what investors should know about this latest FDA warning. The FDA has added a new warning to Johnson & Johnson's COVID-19 vaccine related to a very rare neurological disease.
You should check here to buy the best price guaranteed products.
Israel launches airstrikes on Lebanon in response to rockets
Lakers make decisive but risky moves to overhaul roster
Miley Cyrus Gave Her Thoughts On DaBaby's Homophobic Comments And Said She "Would Love To Talk" To Him
Top Republicans move to protect Trump from Capitol attack fallout
'The builder had sold 130 homes the first day': Foreign buyers may add to housing woes, prices
Man in violent arrest video feared for his life